Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT04991831 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial
NCT04991831 · ClinicalTrials.gov record · last posted 2026-03-20

A Post-Approval Registry for Exablate 4000 Type 1.0 and Type 1.1 for Unilateral Thalamotomy for the Treatment of Medication-Refractory Tremor Dominant Idiopathic Parkinson's Disease

StatusRecruiting
PhaseNot specified
SponsorInSightec
Started2022-04-28
View on ClinicalTrials.gov ↗
from the ClinicalTrials.gov record
The objectives of this study are to collect the long-term safety and effectiveness data of performing thalamotomy for tremor dominant Parkinson's Disease (TDPD) using the Exablate Neuro system.

Amendment record 5 amendments on the ClinicalTrials.gov record

This ClinicalTrials.gov record has been amended 5 times since 2021-07-28; most recent amendment 2026-03-18. DataLookout shows field-level changes from the day a trial enters its daily monitoring; earlier amendments are counted here from the ClinicalTrials.gov version history. See every version on ClinicalTrials.gov ↗

2022-04-28
Status change Not Yet Recruiting→Recruitingv1
Trial Details
NCT Number NCT04991831
Lead Sponsor InSightec
Conditions Tremor Associated With Tremor Dominant Parkinson's Disease
Enrollment 50 participants
Start Date 2022-04-28
Primary Completion 2027-12 (estimated)
Study Completion 2027-12 (estimated)
Updated on ClinicalTrials.gov 2026-03-20